Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wolters-kluwer-health/correction-of-familial-lcat-deficiency-by-aav-hlcat-prevents-renal-9Z7hGFf37T
References (33)
-
(1997)
overexpressing lecithin-cholesteryl acyltransferase -
Mengmeng Guo, Zongyu Liu, Yi-tong Xu, P. Ma, Wei Huang, Mingming Gao, Yuhui Wang, George Liu, X. Xian (2020)
Spontaneous Atherosclerosis in Aged LCAT-Deficient Hamsters With Enhanced Oxidative Stress—Brief ReportArteriosclerosis, Thrombosis, and Vascular Biology, 40
-
K. Manthei, Shyh-Ming Yang, Bolormaa Baljinnyam, Louise Chang, A. Glukhova, W. Yuan, L. Freeman, D. Maloney, A. Schwendeman, A. Remaley, A. Jadhav, John Tesmer (2018)
Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesteroleLife, 7
-
P. Aranda, Pedro Valdivielso, L. Pisciotta, I. García, C. GarcãA-Arias, S. Bertolini, G. MartãN-Reyes, Gonzã Lez-Santos, S. Calandra (2008)
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs).Clinical nephrology, 69 3
-
T. El-Aziz, R. Mohamed, H. Hagrass (2014)
Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism.Journal of clinical lipidology, 8 4
-
R. Shamburek, R. Bakker-Arkema, B. Auerbach, B. Krause, R. Homan, M. Amar, L. Freeman, A. Remaley (2016)
Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.Journal of clinical lipidology, 10 2
-
J. Hoeg, S. Santamarina-Fojo, Annie BE'RARD, J. Cornhill, Edward HERDERICKt, S. Feldman, C. Haudenschild, B. Vaisman, R. Hoyt, S. Demosky, R. Kauffman, Christina Hazel, Santica Marcovinas, H. Brewer (1996)
Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.Proceedings of the National Academy of Sciences of the United States of America, 93 21
-
Zhaoqi Dong, Haozhe Shi, Mingming Zhao, Xin Zhang, Wei Huang, Yuhui Wang, Lemin Zheng, X. Xian, George Liu (2018)
Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis.Metabolism: clinical and experimental, 83
-
L. Fan, J. Drew, M. Dunckley, J. Owen, G. Dickson (1998)
Efficient coexpression and secretion of anti-atherogenic human apolipoprotein AI and lecithin-cholesterol acyltransferase by cultured muscle cells using adeno-associated virus plasmid vectorsGene Therapy, 5
-
B. Vaisman, E. Neufeld, L. Freeman, S. Gordon, M. Sampson, M. Pryor, Emily Hillman, M. Axley, S. Karathanasis, A. Remaley (2018)
LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT DeficiencyThe Journal of Pharmacology and Experimental Therapeutics, 368
-
C. Pavanello, A. Ossoli, M. Turri, A. Strazzella, S. Simonelli, T. Laurenzi, K. Kono, Keisuke Yamada, N. Kiyosawa, I. Eberini, L. Calabresi (2020)
Activation of Naturally Occurring Lecithin:Cholesterol Acyltransferase Mutants by a Novel Activator CompoundThe Journal of Pharmacology and Experimental Therapeutics, 375
-
B. Vaisman, H. Klein, M. Rouis, Annie rard, M. Kindt, G. Talley, S. Meyn, R. Hoyt, S. Marcovina, J. Albers, J. Hoeg, H. Brewer, S. Santamarina-Fojo (1995)
Overexpression of Human Lecithin Cholesterol Acyltransferase Leads to Hyperalphalipoproteinemia in Transgenic Mice (*)The Journal of Biological Chemistry, 270
-
Chun Yang, Wenhong Tian, Sisi Ma, Mengmeng Guo, Xiao Lin, Fengying Gao, Xiao-yan Dong, Mingming Gao, Yuhui Wang, George Liu, X. Xian (2020)
AAV-Mediated ApoC2 Gene Therapy: Reversal of Severe Hypertriglyceridemia and Rescue of Neonatal Death in ApoC2-Deficient HamstersMolecular Therapy. Methods & Clinical Development, 18
-
M Guo, Z Liu, Y Xu, P Ma, W Huang, M Gao, Y Wang, G Liu, X Xian (2020)
Spontaneous atherosclerosis in aged lcat-deficient hamsters with enhanced oxidative stress., 40
-
A. Ossoli, S. Simonelli, C. Vitali, G. Franceschini, L. Calabresi (2016)
Role of LCAT in Atherosclerosis.Journal of atherosclerosis and thrombosis, 23 2
-
C. Vitali, A. Remaley, M. Cuchel (2018)
Is Low-Density Lipoprotein Cholesterol the Key to Interpret the Role of Lecithin: Cholesterol Acyltransferase in Atherosclerosis?Circulation, 138
-
C. Gebhard, D. Rhainds, Gang He, J. Rodés‐Cabau, S. Lavi, J. Spence, L. Title, S. Kouz, P. L'allier, J. Grégoire, R. Ibrahim, M. Cossette, M. Guertin, R. Beanlands, É. Rhéaume, J. Tardif (2018)
Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden.Atherosclerosis, 276
-
N. Vickaryous, E. Teh, B. Stewart, P. Dolphin, C. Too, R. McLeod (2003)
Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward alpha- and beta-substrate lipoproteins.Biochimica et biophysica acta, 1646 1-2
-
A. Mertens, P. Verhamme, J. Bielicki, M. Phillips, R. Quarck, W. Verreth, D. Stengel, E. Ninio, M. Navab, B. Mackness, M. Mackness, P. Holvoet (2003)
Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice: LCAT Gene Transfer Decreases AtherosclerosisCirculation: Journal of the American Heart Association, 107
-
A. Mehlum, M. Muri, T. Hagve, L. Solberg, H. Prydz (1997)
Mice overexpressing human lecithin: cholesterol acvltransferase are not protected against diet‐induced atherosclerosisAPMIS, 105
-
X. Rousset, B. Vaisman, B. Auerbach, B. Krause, R. Homan, J. Stonik, G. Csako, R. Shamburek, A. Remaley (2010)
Effect of Recombinant Human Lecithin Cholesterol Acyltransferase Infusion on Lipoprotein Metabolism in MiceJournal of Pharmacology and Experimental Therapeutics, 335
-
S. Homma, N. Murayama, T. Kodama, N. Yamada, K. Takahashi, Y. Asano, S. Hosoda, T. Murase, Y. Akanuma (1993)
Effects of long-term, low-fat diet on plasma apo E in familial LCAT deficiency.Nihon Jinzo Gakkai shi, 35 8
-
C. Manno, V. Arruda, G. Pierce, B. Glader, M. Ragni, J. Rasko, M. Ozelo, K. Hoots, P. Blatt, B. Konkle, M. Dake, R. Kaye, M. Razavi, A. Zajko, J. Zehnder, H. Nakai, A. Chew, D. Leonard, D. Leonard, J. Wright, R. Lessard, J. Sommer, M. Tigges, D. Sabatino, A. Luk, Haiyan Jiang, F. Mingozzi, L. Couto, H. Ertl, K. High, K. High, M. Kay (2006)
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune responseNature Medicine, 12
-
I. Castro-Ferreira, R. Carmo, S. Silva, O. Corrêa, S. Fernandes, S. Sampaio, Rodrigues-Pereira Pedro, A. Praça, J. Oliveira (2018)
Novel Missense LCAT Gene Mutation Associated with an Atypical Phenotype of Familial LCAT Deficiency in Two Portuguese Brothers.JIMD reports, 40
-
Shokichi Naito, Mariko Kamata, M. Furuya, Miyuki Hayashi, Masayuki Kuroda, H. Bujo, K. Kamata (2013)
Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT deficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment.Atherosclerosis, 228 1
-
S. Ylä-Herttuala (2012)
Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union.Molecular therapy : the journal of the American Society of Gene Therapy, 20 10
-
M. Amar, R. Shamburek, B. Vaisman, C. Knapper, B. Foger, R. Hoyt, S. Santamarina-Fojo, H. Brewer, A. Remaley (2009)
Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein.Metabolism: clinical and experimental, 58 4
-
S. Séguret-Macé, M. Latta-Mahieu, G. Castro, G. Luc, J. Fruchart, E. Rubin, P. Denéfle, N. Duverger (1996)
Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene.Circulation, 94 9
-
F. Oldoni, D. Baldassarre, S. Castelnuovo, A. Ossoli, M. Amato, J. Capelleveen, G. Hovingh, E. Groot, A. Bochem, S. Simonelli, Simone Barbieri, F. Veglia, G. Franceschini, J. Kuivenhoven, A. Holleboom, L. Calabresi (2018)
Complete and Partial Lecithin: Cholesterol Acyltransferase Deficiency Is Differentially Associated With AtherosclerosisCirculation, 138
-
M. Yee, D. Pavitt, W. Richmond, H. Cook, A. Mclean, J. Valabhji, R. Elkeles (2009)
Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy.Atherosclerosis, 205 2
-
A. Bérard, B. Föger, A. Remaley, R. Shamburek, B. Vaisman, G. Talley, B. Paigen, R. Hoyt, S. Marcovina, H. Brewer, S. Santamarina-Fojo (1997)
High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferaseNature Medicine, 3
-
Homma S (1993)
999Nihon Jinzo Gakkai Shi., 35
-
M. Sasaki, Mina Delawary, Hidetaka Sakurai, Hideki Kobayashi, Naoki Nakao, Hiromi Tsuru, Yumiko Fukushima, Shoko Honzumi, S. Moriyama, Naoya Wada, Toshio Kaneko, Keisuke Yamada, N. Terasaka, K. Kubota (2020)
Novel LCAT (Lecithin:Cholesterol Acyltransferase) Activator DS-8190a Prevents the Progression of Plaque Accumulation in Atherosclerosis ModelsArteriosclerosis, Thrombosis, and Vascular Biology, 41
- Publisher
- Wolters Kluwer Health
- Copyright
- © 2021 American Heart Association, Inc.
- ISSN
- 1079-5642
- eISSN
- 1524-4636
- DOI
- 10.1161/atvbaha.120.315719
- Publisher site
- See Article on Publisher Site
Abstract
Supplemental Digital Content is available in the text.
Journal
Arteriosclerosis Thrombosis and Vascular Biology – Wolters Kluwer Health
Published: Jul 13, 2021